** Shares of Australia's Control Bionics CBL.AX rise as much as 4.8% to A$0.044, its highest level since February 17
** The medical device manufacturer raises A$2.0 million ($1.27 million) via private placement at an issue price of A$0.045 per share
** Issue price represents a premium of 7.1% to stock's last closing
** Funds raised to help the company "focus on revenue growth in its core operations and the expansion into new high-potential markets" — CBL
** Stock has fallen 26.7% this year, as of 0118 GMT
($1 = 1.5778 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。